Type 1 Diabetes

Overview: The trial is designed to evaluate the safety of CNP-103 and explore if it may help protect insulin-producing beta cells that support better blood sugar control.

Overview: This study evaluates the safety and effectiveness of a medication aiming to preserve function of insulin producing cells.

Overview: You could be part of a clinical study programme that helps get more information on how a new, once-weekly insulin product, helps in reducing the blood sugar compared with insulin products taken once daily.

Overview: This study is testing an investigational study drug in people recently diagnosed with type 1 diabetes.